| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $112.5M | +12.4% |
| SG&A Expense | $33.1M | +8.0% |
| Operating Income | -$145.6M | -11.4% |
| Pre-tax Income | $141.9M | +208.9% |
| Net Income | -$141.9M | -8.9% |
| EPS (Basic) | -$2.60 | +23.5% |
| EPS (Diluted) | -$2.60 | +23.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $140.0M | +87.1% |
| Current Assets | $248.1M | +0.2% |
| Total Assets | $285.1M | -0.7% |
| Current Liabilities | $22.4M | +2.8% |
| Total Liabilities | $53.9M | -2.2% |
| Stockholders' Equity | $231.2M | -0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$116.3M | -9.6% |
| Capital Expenditures | $6.5M | +294.6% |
| Investing Cash Flow | $58.4M | +166.2% |
| Financing Cash Flow | $122.9M | +6747.2% |
| Free Cash Flow | -$122.8M | -14.0% |